Related references
Note: Only part of the references are listed.Blastomycosis in solid organ transplant recipients
G. M. Gauthier et al.
TRANSPLANT INFECTIOUS DISEASE (2007)
Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen
Sergio M. Borgia et al.
MEDICAL MYCOLOGY (2006)
Urine antigen detection of blastomycosis in pediatric patients
Kanokporn Mongkolrattanothai et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Voriconazole therapeutic drug monitoring
J Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole
J Panicker et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
The epidemiology of blastomycosis in Illinois and factors associated with death
MS Dworkin et al.
CLINICAL INFECTIOUS DISEASES (2005)
A case of blastomycosis in pregnancy
MA Pipitone et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex
JR Perfect
CLINICAL INFECTIOUS DISEASES (2005)
Successful treatment of cerebral blastomycosis with voriconazole
M Bakleh et al.
CLINICAL INFECTIOUS DISEASES (2005)
Antigen assay with the potential to aid in diagnosis of blastomycosis
M Durkin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy
M Goldman et al.
CLINICAL INFECTIOUS DISEASES (2004)
Blastomycosis in Missouri: epidemiology and risk factors for endemic disease
MV Cano et al.
EPIDEMIOLOGY AND INFECTION (2003)
In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: Comparison of yeast-like and mycelial forms
T Nakai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Voriconazole: A new triazole antifungal agent
LB Johnson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Cutaneous inoculation blastomycosis
NA Gray et al.
CLINICAL INFECTIOUS DISEASES (2002)
Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals
TL Crampton et al.
CLINICAL INFECTIOUS DISEASES (2002)
Pulmonary blastomycosis - An appraisal of diagnostic techniques
MA Martynowicz et al.
CHEST (2002)
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
DW Denning et al.
CLINICAL INFECTIOUS DISEASES (2002)
Efficacy of voriconazole in treatment of murine pulmonary blastomycosis
AM Sugar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Pregnancy outcome after in utero exposure to itraconazole: A prospective cohort study
B Bar-Oz et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid-organ transplant recipients with invasive fungal infections
P Linden et al.
CLINICAL TRANSPLANTATION (2000)
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system
AH Groll et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis and Histoplasma capsulatum
RK Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Recurrent blastomycosis of the central nervous system: Case report and review
A Chowfin et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
